FDA Clearance Tracker · P070026-S063
Ceramax Ceramic Total Hip System
Last checked: Nov 20, 2026Latest source record: Jul 19, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 19, 2019
Approved
Time to decision
59 days
Received May 21, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P070026-S063
- Device name
- Ceramax Ceramic Total Hip System
- Applicant
- DePuy Orthopaedics, Inc.
- Applicant location
- Warsaw, IN
- Received
- May 21, 2019
- Decided
- Jul 19, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P070026
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for several changes to the approved post-approval study (PAS) protocol for the 36mm (COC36) newly enrolled subjects including, allowing any AP and Lateral radiographs that provide the required data points, expanding the time window for pre-op radiographs, and allowing telephone follow-up for 3- and 4-year visits.
Source documents
Other decisions for DePuy Orthopaedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262130 · Decided Sep 4, 2026 · 72 days after receipt
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.